Related Experiment Video
Updated: Aug 11, 2026
Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
Classification of AML using a monoclonal antibody microarray
Richard I Christopherson1, Kerryn Stoner, Nicole Barber
1School of Molecular and Microbial Biosciences, University of Sydney, NSW, Australia.
Insights
The DotScan microarray offers a comprehensive immunophenotype analysis for leukocytes, crucial for identifying leukemia. This technology aids in diagnosing myeloid leukemias by comparing cell patterns to established leukemia profiles.
Area of Science:
- Hematology
- Immunology
- Biotechnology
Background:
- Accurate immunophenotyping of leukocytes is essential for diagnosing hematological malignancies.
- Existing methods can be time-consuming and require multiple analyses.
Purpose of the Study:
- To introduce the DotScan microarray for extensive immunophenotyping of leukocytes.
- To evaluate its utility in the diagnosis of leukemia, particularly myeloid leukemias.
Main Methods:
- Development of the DotScan microarray using immobilized cluster of differentiation (CD) antibodies on a nitrocellulose film.
- Analysis of leukocyte suspensions to capture cells by immobilized antibodies.
- Recording dot patterns using an optical array reader to determine the immunophenotype.
Main Results:
- The DotScan microarray provides an extensive immunophenotype in a single analysis.
- For leukemias with high counts, the immunophenotype reflects the leukemic clone.
- Development of procedures for diagnosing myeloid leukemias by comparing obtained dot patterns with a library of consensus patterns.
Conclusions:
- The DotScan microarray is a powerful tool for comprehensive leukocyte immunophenotyping.
- This technology shows promise for the rapid and accurate diagnosis of myeloid leukemias.
- Further development aims to establish a diagnostic library for common leukemias.
Abstract:
A cluster of differentiation (CD) antibody microarray called the DotScan microarray has been developed that enables an extensive immunophenotype to be obtained for a suspension of leukocytes in a single analysis. For a leukemia with a leukemia count of greater than 10 x 10(9)/L, the immunophenotype obtained is essentially that of the leukemic clone. The antibody microarray is printed as microscopic (10 nL) dots on a nitrocellulose film on a microscope slide. Cells are captured by the immobilized antibodies and a dot pattern is recorded with an optical array reader giving the immunophenotype of the leukemia. Procedures are being developed that should enable diagnosis of myeloid leukemias by comparison of the dot pattern obtained from an unknown blood sample with a library of consensus patterns for the common leukemias.